Bespoke Extracts (Bespoke Extracts) Investments And Advances : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Bespoke Extracts Investments And Advances?

Bespoke Extracts's Investments And Advances for the quarter that ended in Dec. 2023 was $0.00 Mil.

Bespoke Extracts Investments And Advances Historical Data

The historical data trend for Bespoke Extracts's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bespoke Extracts Investments And Advances Chart

Bespoke Extracts Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Dec22

Dec23

Investments And Advances

Get a 7-Day Free Trial

Bespoke Extracts Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Investments And Advances	Get a 7-Day Free Trial															-	-	-	-	-

Bespoke Extracts Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

Bespoke Extracts (Bespoke Extracts) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bespoke Extracts Inc (OTCPK:BSPK) » Definitions » Investments And Advances

Comparable Companies

Traded in Other Exchanges

N/A

Address

12001 E. 33rd Avenue, Unit O, Aurora, Denver, CO, USA, 80010

Website

https://bespokeextracts.com

Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products. It unveiled a new brand image and a new line-up of seven hemp-derived CBD formulations available for purchase in the form of tinctures and softgels.

Executives

Michael Feinsod	director, 10 percent owner, officer: CEO
Tyler Hunter Garth	director, officer: President	6300 E HAMPDEN AVE, 2306, DENVER CO 80222
Danil Pollack	10 percent owner, officer: President and CEO	6 GAUGUIN AVE., VAUGHAN A6 L4J9J7
Niquana Monique Noel	10 percent owner, officer: President and CEO	1316 SW 3RD COURT, FT. LAUDERDALE FL 33312
Marc Yahr	director, 10 percent owner, officer: President and CEO	1966 NE 123RD STREET, NUM 170, NORTH MIAMI FL 33181
Anthony Ivankovich	10 percent owner	971 CRANDON BLVD., APT. PH-6, KEY BISCAYNE FL 33149
Mcglothlin Holdings, Ltd.	10 percent owner	402 W. DAVIS, LULING TX 78648
Barry Tenzer	director, 10 percent owner, officer: President, CEO, CFO	290 LENOX AVENUE, NEW YORK NY 10027
Roberto Fata	director, 10 percent owner, officer: Executive VP	290 LENOX AVENUE, SECOND FLOOR, NEW YORK NY 10027
Lyle Hauser	10 percent owner	290 LENOX AVENUE, SECOND FLOOR, NEW YORK NY 10027